These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
343 related items for PubMed ID: 14739623
1. Acquired von Willebrand syndrome: its pathophysiology, laboratory features and management. Mohri H. J Thromb Thrombolysis; 2003 Jun; 15(3):141-9. PubMed ID: 14739623 [Abstract] [Full Text] [Related]
2. Acquired von Willebrand syndrome: features and management. Mohri H. Am J Hematol; 2006 Aug; 81(8):616-23. PubMed ID: 16823821 [Abstract] [Full Text] [Related]
3. Acquired von Willebrand syndromes: clinical features, aetiology, pathophysiology, classification and management. Michiels JJ, Budde U, van der Planken M, van Vliet HH, Schroyens W, Berneman Z. Best Pract Res Clin Haematol; 2001 Jun; 14(2):401-36. PubMed ID: 11686107 [Abstract] [Full Text] [Related]
4. Diagnosis and management of acquired von Willebrand syndrome. Federici AB, Mannucci PM. Clin Adv Hematol Oncol; 2003 Mar; 1(3):169-75. PubMed ID: 16224398 [Abstract] [Full Text] [Related]
15. Acquired von Willebrand syndrome: an underdiagnosed and misdiagnosed bleeding complication in patients with lymphoproliferative and myeloproliferative disorders. Federici AB. Semin Hematol; 2006 Jan; 43(1 Suppl 1):S48-58. PubMed ID: 16427386 [Abstract] [Full Text] [Related]
17. Review article: unexpected bleeding in the operating room: the role of acquired von Willebrand disease. Lison S, Dietrich W, Spannagl M. Anesth Analg; 2012 Jan; 114(1):73-81. PubMed ID: 22025497 [Abstract] [Full Text] [Related]
18. Dominant von Willebrand disease type 2A groups I and II due to missense mutations in the A2 domain of the von Willebrand factor gene: diagnosis and management. Michiels JJ, van Vliet HH. Acta Haematol; 2009 Jan; 121(2-3):154-66. PubMed ID: 19506362 [Abstract] [Full Text] [Related]
19. Diagnosis and treatment of acquired von Willebrand syndrome. Tiede A. Thromb Res; 2012 Dec; 130 Suppl 2():S2-6. PubMed ID: 23439003 [Abstract] [Full Text] [Related]
20. Guidelines for the evaluation of intravenous desmopressin and von Willebrand factor/factor VIII concentrate in the treatment and prophylaxis of bleedings in von Willebrand disease types 1, 2, and 3. Michiels JJ, Gadisseur A, van der Planken M, Schroyens W, van de Velden A, Berneman Z. Semin Thromb Hemost; 2006 Sep; 32(6):636-45. PubMed ID: 16977574 [Abstract] [Full Text] [Related] Page: [Next] [New Search]